Role of type 1 versus type 2 immune responses in liver during the onset of chronic woodchuck hepatitis virus infection

Hepatology

Volumn 37, Issue 4, 2003, Pages 771-780

  Wang, Yun ^a   Menne, Stephan ^b   Jacob, James R ^b   Tennant, Bud C ^b   Gerin, John L ^a   Cote, Paul J ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL MARKER; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; STAT4 PROTEIN; STAT6 PROTEIN; TRANSCRIPTION FACTOR GATA 3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE SEVERITY; HEPATITIS VIRUS; IMMUNE RESPONSE; MOLECULAR BIOLOGY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOODCHUCK;

EID: 0037380585     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50154     Document Type: Article

References (46)

1. Popper H, Shafritz DA, Hoofnagle JH. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. HEPATOLOGY 1987;7:764-772.
2. Chang KM, Chisari FV. Immunopathogenesis of hepatitis B virus infection. Clin Liver Dis 1999;3:221-239.
3. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Ann Rev Immunol 1995;13:29-60.
4. Chisari FV, Ferrari C. Viral hepatitis. In: Nathanson N, ed. Viral Pathogenesis. Philadelphia: Lippincott-Raven, 1997:745-778.
5. Guidotti LG, Chisari FV. Non-cytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001;19:65-91.
6. Milich DR. Immune response to hepatitis B virus: infection, animal models, vaccination. Viral Hepat Rev 1997;3:63-103.
7. Cote PJ, Korba BE, Steinberg H, Ramirez-Meija C, Baldwin BH, Hornbuckle WE, Tennant BC, et al. Cyclosporin A modulates the course of woodchuck hepatitis virus infection and induces chronicity. J Immunol 1991;146:3138-3144.
8. Cote PJ, Korba BE, Baldwin BH, Hornbuckle WE, Tennant BC, Gerin JL. Immunosuppression with cyclosporine during the incubation period of experimental woodchuck hepatitis virus infection increases the frequency ofchronic infection in adult woodchucks. J Infect Dis 1992; 166:628-631.
9. Cote PJ, Gerin JL. In vitro activation of woodchuck lymphocytes measured by radiopurine incorporation and interleukin-2 production: implications for modeling immunity and therapy in hepatitis B virus infection. HEPATOLOGY 1995;22:687-699.
10. Menne S, Maschke J, Lu M, Grosse-Wilde H, Roggendorf M. T-cell response to woodchuck hepatitis virus (WHV) antigens during acute selflimited WHV infection and convalescence and after viral challenge. J Virol 1998;72:6083-6091.
11. Menne S, Maschke J, Tolle TK, Lu M, Roggendorf M. Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope. J Virol 1997;71:65-74.
12. Cote PJ, Korba BE, Miller RH, Jacob JR, Baldwin BH, Hornbuckle WE, Purcell RH, et al. Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection. HEPATOLOGY 2000;31:190-200.
13. Cote PJ, Toshkov I, Bellezza C, Ascenzi M, Roneker C, Ann Graham L, Baldwin BH, et al. Temporal pathogenesis of experimental neonatal woodchuck hepatitis virus infection: increased initial viral load and decreased severity of acute hepatitis during the development of chronic viral infection. HEPATOLOGY 2000;32:807-817.
14. Nakamura I, Nupp JT, Cowlen M, Hall WC, Tennant BC, Casey JL, Gerin JL, et al. Pathogenesis of neonatal woodchuck hepatitis virus infection: chronicity as an outcome of infection is associated with a diminished acute hepatitis that is temporally deficient for the expression of interferongamma and tumor necrosis factor-alpha messenger RNAs. HEPATOLOGY 2001;33:439-447.
15. Menne S, Roneker CA, Gerin JL, Cote PJ, Tennant BC. Deficiencies in the acute phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation. J Virol 2002;76:1769-1780.
16. Peek SF, Cote PJ, Jacob JR, Toshkov IA, Hornbuckle WE, Baldwin BH, Wells FV, et al. Antiviral activity ofclevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks. HEPATOLOGY 2001;33:254-266.
17. Menne S, Ronecker CA, Korba BE, Gerin JL, Tennant BC, Cote PJ. Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-β-L-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection. J Virol 2002;76:5305-5314.
18. Cote PJ, Gerin JL. The woodchuck as a model of hepadnavirus infection, pathogenesis and therapy. FORUM Trends Exp Clin Med 1996;6:131-159.
19. Cote PJ, Nakamura I, Bellezza C, Tennant BC, Gerin GL. Immunobiology of the woodchuck and woodchuck hepatitis virus infection. In: Rizzetto M, Purcell R, Gerin J, Verme G, eds. Viral Hepatitis and Liver Disease. Turin: Edizioni Minerva Medica, 1997:157-163.
20. Menne S, Tennant BC. Unraveling hepatitis B virus infection of mice and men (and woodchucks and ducks). Nat Med 1999;10:1125-1126.
21. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996;272:50-53.
22. Rao A, Avni O. Molecular aspects of T-cell differentiation. Br Med Bull 2000;56:969-984.
23. Kao CT, Leiden JM. Transcriptional regulation of T lymphocyte development and function. Annu Rev Immunol 1999;17:149-187.
24. Lighvani AA, Frucht DM, Jankovic D, Yamane H, Aliberti J, Hissong BD, Nguyen BV, et al. T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells. Proc Natl Acad Sci U S A 2001;98:15137-15142.
25. Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 2002;295:338-342.
26. Mullen AC, High FA, Hutchins AS, Hubert HW, Villarino AV, Livingston DM, Kung AL, et al. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 2001;292:1907-1910.
27. Das J, Chen CH, Yang L, Cohn L, Ray P, Ray A. A critical role for NF-κB on GATA3 expression and Th2 differentiation in allergic airway inflammation. Nat Immunol 2001:245-250.
28. Concannon PW, Roberts P, Baldwin BH, Tennant BC. Long-term entrainment of circannual reproductive and metabolic cycles by northern and southern hemisphere photoperiods in woodchucks (Marmota monax). Biol Reprod 1997;57:1008-1015.
29. Cote PJ, Roneker C, Cass K, Schoedel F, Peterson D, Tennant BC, De Noronha F, et al. New enzyme immunoassays for the serologic detection of woodchuck hepatitis virus infection. Viral Immunol 1993;161-169.
30. Hornbuckle WE, Graham ES, Roth L, Baldwin BH, Wickenden C, Tennant BC. Laboratory assessment of hepatic injury in the woodchuck. Lab Anim Sci 1985;35:376-381.
31. Wu TT, Coates L, Aldrich CE, Summers J, Mason WS. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology 1990;175:255-261.
32. Nakamura I, Nupp JT, Rao BS, Buckler-White A, Casey JL, Gerin JL, Cote PJ. Cloning and characterization of partial cDNAs for woodchuck cytokines and CD3ε with applications for the detection of RNA expression in tissues by RT-PCR assay. J Med Virol 1997;53:85-95.
33. Menne S, Wang Y, Butler SD, Gerin JL, Cote PC, Tennant BC. Real-time polymerase chain reaction assays for leukocyte CD and cytokine mRNAs of the Eastern woodchuck (Marmota monax). Ver Immunol Immunopathol 2002;87:97-105.
34. Popper H, Popper H, Roth L, Purcell RH, Tennant BC, Gerin JL. Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc Natl Acad Sci U S A 1987;84:866-870.
35. Lu M, Lohrengel B, Hilken G, Kemper T, Roggendorf M. Woodchuck gamma interferon upregulates major histocompatibility complex class I transcription but is unable to deplete woodchuck hepatitis virus replication intermediates and RNAs in persistently infected woodchuck primary hepatocytes. J Virol 2002;76:58-67.
36. Guo JT, Zhou H, Liu C, Aldrich C, Saputelli J, Whitaker T, Barrasa MI, et al. Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections. J Virol 2000;74:1495-1505.
37. Hodgson PD, Michalak TI. Augmented hepatic interferon gamma expression and T-cell influx characterize acute hepatitis progressing to recovery and residual lifelong persistence in experimental adult woodchuck hepatitis virus infection. HEPATOLOGY 2001;34:10049-10059.
38. Bertoletti A, D'Elios MM, Boni C, De Carli M, Zignego AL, Durazzo M, Missale G, et al. Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 1997;112:193-199.
39. Kakumu S, Ishikawa T, Wakita T, Yoshioka K, Takayanagi M, Tahara H, Kusakabe A. Interferon-gamma production specific for hepatitis B virus antigens by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B. Am J Gastroenterol 1994;89:92-96.
40. + cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000;191:1269-1280.
41. Marinos G, Torre F, Chokshi S, Hussain M, Clarke BE, Rowlands DJ, Eddleston AL, et al. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. HEPATOLOGY 1995;22:1040-1049.
42. Webster GJ, Reignat S, Maini MK, Whalley SA, Ogg GS, King A, Brown D, et al. Incubation phase ofacute hepatitis B in man: dynamic of cellular immune mechanisms. HEPATOLOGY 2000;32:1117-1124.
43. Chisari FV. Hepatitis B virus transgenic mice: models of viral immunology and pathogenesis. Curr Top Microbiol Immunol 1996;206:149-173.
44. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell RH, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999;284:825-829.
45. + T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003;77:68-76.
46. Hodgson PD, Grant MD, Michalak TI. Perforin and Fas/Fas ligandmediated cytotoxicity in acute and chronic woodchuck viral hepatitis. Clin Exp Immunol 1999;118:63-70.